WebDr. Jeremy Richmon is a fellowship-trained head and neck surgeon who specializes in head and neck cancer and microvascular reconstruction. Dr. Richmon is a pioneer in minimally-invasive robotic techniques in the … WebDr. Richon currently serves as the president and chief executive officer of Ribon Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions. Prior to Ribon, she was vice president, global head of ...
HotSpot Therapeutics Expands Board of Directors and …
WebFeb 17, 2024 · Dr. Raman has succeeded Victoria Richon, Ph.D., in these roles. Dr. Richon will remain actively involved in the Company as an R&D advisor to the Board of Directors and Chair of the Scientific Advisory Board, where she will work closely with Dr. Raman and executive leadership to advance Ribon’s scientific activities. WebJan 6, 2024 · Victoria Richon is CEO of Entact Bio. After studying mechanisms of chemotherapy resistance as a graduate student in the ‘80s, the newly minted Dr. Richon sought to leverage her work to help patients: “I went to Sloan Kettering because I wanted to continue doing cancer research, but with a translational focus.”. new jersey transit human resources contact
Ribon Therapeutics, a Clinical Stage Biotechnology Company …
WebBest Dentists in Fawn Creek Township, KS - Patrzykont John A DDS, Jennifer M Beurskens, DDS, Blaich Gary DDS PA, Barone Roy N DDS, Robert L. Mason, DDS, Zent Dennis J … WebDr. Richon will remain actively involved in the Company as an R&D advisor to the Board of Directors and Chair of the Scientific Advisory Board, where she will work closely with Dr. Raman and executive leadership to advance Ribon’s scientific activities. Schedule your 30 min Free 1stOncology Demo! WebSep 4, 2024 · Dr. Richon brings extensive research and development experience to help support the future growth of Epizyme’s product pipeline, including having served as vice president of biological sciences at Epizyme from 2008 to 2012. During that time she played a key role in bringing forward two first-in-class agents from initiation of discovery to ... in this data set what is the mode 6 7 10 12